Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine

Author： Robson Philip  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.5, 2011-09, pp. : 675-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5113-5130

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis

By Lu Lanting   Pearce Hilary  

PharmacoEconomics, Vol. 30, Iss. 12, 2012-12 ,pp. : 1157-1171

Adis International

Access to resources Recommend Favorite

The effects of 9 -tetrahydrocannabinol physical dependence on brain cannabinoid receptors

By Breivogel C.S.   Scates S.M.   Beletskaya I.O.   Lowery O.B.   Aceto M.D.   Martin B.R.  

European Journal of Pharmacology, Vol. 459, Iss. 2, 2003-01 ,pp. : 139-150

Elsevier

Access to resources Recommend Favorite

Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4966-4979

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite